Related Experiment Video

Updated: Sep 14, 2026

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
06:34

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography

Published on: October 28, 2020

Screening for treatable left ventricular abnormalities in diabetic patients

Adelle Dawson1, Allan D Struthers

  • 1Department of Clinical Pharmacology & Therapeutics, University of Dundee, Ninewells Hospital, Dundee, DD1 9SY, Scotland, UK. a.z.dawson@dundee.ac.uk

Expert Opinion on Biological Therapy
|April 30, 2003
PubMed

Insights

Diabetic patients often die from cardiovascular disease, not just coronary artery disease. Screening for left ventricular dysfunction and hypertrophy using B-type natriuretic peptide (BNP) can identify at-risk individuals for targeted therapy.

Area of Science:

  • Cardiology
  • Diabetology
  • Biomarkers

Background:

  • Cardiovascular disease is the primary cause of mortality in diabetic patients.
  • Current prevention strategies predominantly focus on coronary artery disease.
  • Left ventricular dysfunction (LVD) and left ventricular hypertrophy (LVH) are significant contributors to cardiac mortality in diabetes.

Purpose of the Study:

  • To highlight LVD and LVH as critical, screenable cardiac complications in diabetes.
  • To propose plasma B-type natriuretic peptide (BNP) as a prescreening tool for cardiac abnormalities.
  • To emphasize the prognostic benefits of early detection and treatment of asymptomatic left ventricular abnormalities.

Main Methods:

  • Review of existing literature on cardiovascular complications in diabetes.
  • Discussion of the role of LVD and LVH in diabetic cardiac mortality.
  • Proposal of plasma BNP as a biomarker for identifying patients requiring further cardiac evaluation.

Main Results:

  • Coronary artery disease is not the only cause of cardiac death in diabetics.
  • LVD and LVH are prevalent and treatable causes of cardiac mortality in this population.
  • Plasma BNP levels can indicate the likelihood of underlying left ventricular abnormalities.

Conclusions:

  • Screening for LVD and LVH in diabetic patients is crucial.
  • Plasma BNP offers a potential method for prescreening to identify patients for echocardiography.
  • Early identification and targeted therapy for left ventricular abnormalities improve outcomes in diabetic patients.

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...